Twist Bioscience Corp

Twist Bioscience Corporation develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's core technology manufactures synthetic DNA by "writing" DNA on a silicon chip. This method miniaturizes traditional chemical DNA synthesis reactions, allowing the company to write over 1,000,000 oligonucleotides up to 500 bases through direct synthesis on each silicon chip. This process reduces the estimated amount of chemicals used per gene by 99.8% compared to plate-based synthesis. Twist Bioscience combines its silicon-based DNA writing technology with proprietary software, scalable commercial infrastructure, and an e-commerce platform. From this integrated platform, the company manufactures a broad range of products, including synthetic genes, tools for next generation sequencing (NGS), and sample preparation products. It also provides products and services for drug discovery and development. Twist Bioscience sells its products and services to a global customer base of more than 3,800 customers across various industries, including health care, food/agriculture, industrial chemicals/materials, and academic research.